Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on April 4, 2025
Personalized Addiction Treatment at AmbienceRecovery.com Proves Life-Changing for Clients in Los Angeles
EIN Presswire
·
April 4, 2025
AmbienceRecovery.com is making waves in Los Angeles for its highly personalized addiction treatment program, which has helped clients achieve lasting recovery. LOS ANGELES, CA, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- Where Personalized Care …
Connecting Communities: Care Sector Event Offers Local Networking Zones
EIN Presswire
·
April 4, 2025
LONDON, CA, UNITED KINGDOM, April 3, 2025 /EINPresswire.com/ -- 2025 will see one of the UK’s most exciting care sector gatherings – and this year, it comes with a strong focus on community connection and collaboration. The Care Providers …
ACC.25 Panel of Experts Awards VisCardia Top Honors for Innovation in MedTech
EIN Presswire
·
April 4, 2025
VisCardia wins ACC.25 Innovation Pitch Competition Award PORTLAND, OR, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- VisCardia, Inc. is honored to announce that our team has won the judge’s vote during the Future Hub ACC.25 Innovation Pitch …
Global Clinical Trials Support Services Market to Reach USD 46.2 Billion by 2033 Rising R&D Investments
EIN Presswire
·
April 4, 2025
The Clinical Trials Support Services Market is expected to grow from an estimated USD 21.3 billion in 2024 to USD 46.2 billion in 2033, at a CAGR of 8.00%. VANCOUVER, BRITISH COLUMBIA, CANADA, April 4, 2025 /EINPresswire.com/ -- The research may be …
Global Bioprosthetics Market Increasing Size, Demand, Growth Rate, and Forecast 2033 - Emergen Research
EIN Presswire
·
April 4, 2025
The advancements in medical technology the increasing prevalence of chronic conditions like cardiovascular diseases osteoarthritis are further propelling VANCOUVER, BRITISH COLUMBIA, CANADA, April 4, 2025 /EINPresswire.com/ -- Emergen Research's …
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
GlobeNewswire
·
April 4, 2025
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and …
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
GlobeNewswire
·
April 4, 2025
Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second quarter of 2025 SOUTH SAN FRANCISCO, Calif …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan
GlobeNewswire
·
April 4, 2025
BAODING, China, April 05, 2025 (GLOBE NEWSWIRE) -- European Wellness Biomedical Group (EWBG), a global pioneer in bioregenerative medicine and wellness innovation, today unveiled new breakthroughs in autism-focused therapies under the leadership of Prof. …
Edesa Biotech Announces Chief Financial Officer Transition
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the appointment of Peter J. Weiler …
Jade Guerra Warns of Increasing Migraine Cases Tied to Digital Overuse
EIN Presswire
·
April 4, 2025
Jade Guerra, a chiropractic expert and registered nurse. She warns that more people are getting migraines because of too much screen time. DALLAS, TX, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- As more people spend time on digital devices, …
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2025 the Company granted inducement …
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award consisting of non-qualified stock options to …
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NAARDEN, the Netherlands and MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029
GlobeNewswire
·
April 4, 2025
Boston, April 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Bioprocess Optimization and Digital Bio-manufacturing: Global Markets” is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a …
American Nurses Enterprise Names New Chief Nursing Officer
GlobeNewswire
·
April 4, 2025
SILVER SPRING, MD, April 04, 2025 (GLOBE NEWSWIRE) -- The American Nurses Enterprise, which includes the American Nurses Association, the American Nurses Credentialing Center, and the American Nurses Foundation, is pleased to announce the appointment of …
Dr. Jonathan Odinsky of Infinity Dental Wellness Awarded As 2024 NJ Top Dentist
EIN Presswire
·
April 4, 2025
NJ Top Dentists has reviewed and approved Dr. Jonathan Odinsky of Infinity Dental Wellness based on merit for 2024. FORT LEE, NJ, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- NJ Top Dentists has reviewed and approved Dr. Jonathan Odinsky of …